ClinicalTrials.Veeva

Menu

Occipital Nerve Stimulation in Trigeminal Autonomic Cephalgias

A

Alberta Health Services, Calgary

Status

Enrolling

Conditions

Trigeminal Autonomic Cephalgia

Treatments

Procedure: Occipital nerve stimulator implant

Study type

Interventional

Funder types

Other

Identifiers

NCT04937010
REB21-0839

Details and patient eligibility

About

The objective of this study is to determine the efficacy of occipital nerve stimulation (ONS) in the treatment of chronic trigeminal autonomic cephalalgias (TACs).

Full description

Several open studies and case series have shown improvement in pain scores using ONS specifically for cluster headache, which is the most common of the TACs. However, neuromodulation in the treatment of pain disorders is subject to strong placebo effect and bias, and the lack of controlled studies in this population makes its true efficacy unknown. Therefore, we plan to study ONS in a population of patients with chronic TACs using a double-blind, randomized, controlled, cross-over study. Using sub-threshold stimulation parameters, meaning patients will not know when therapeutic stimulation is active, subjects will rate their pain and quality of life during both therapeutic and sham stimulation periods. Following the cross-over period, all subjects will undergo therapeutic stimulation for 1-year in order to gauge long-term effects.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meets ICHD-3 diagnostic criteria for the chronic form of one of the trigeminal autonomic cephalgias (outlined below), as determined by the treating neurologist.
  • Failed standard medical management, meaning at least 3 conventional preventative therapies.

Exclusion criteria

  • Presence of uncontrolled or untreated psychiatric disease
  • Presence of medical contraindications to surgery
  • Patient does not consent to surgery
  • Non-English speaking

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

20 participants in 2 patient groups

Industry standard stimulation
Active Comparator group
Description:
Standard sub threshold stimulation parameters
Treatment:
Procedure: Occipital nerve stimulator implant
Experimental stimulation
Sham Comparator group
Description:
Sham stimulation
Treatment:
Procedure: Occipital nerve stimulator implant

Trial contacts and locations

1

Loading...

Central trial contact

Fady Girgis, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems